{"id":26973,"date":"2021-04-19T13:18:50","date_gmt":"2021-04-19T13:18:50","guid":{"rendered":"https:\/\/scienceblog.cancerresearchuk.org\/?p=18440"},"modified":"2024-11-03T15:14:58","modified_gmt":"2024-11-03T15:14:58","slug":"whos-plans-to-create-a-cervical-cancer-free-future","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/whos-plans-to-create-a-cervical-cancer-free-future\/","title":{"rendered":"WHO\u2019s plans to create a \u2018cervical cancer-free future\u2019"},"content":{"rendered":"<div class=\"image hero-image\"><img decoding=\"async\" width=\"620\" height=\"348\" src=\"https:\/\/zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com\/wp-content\/uploads\/2021\/04\/Cervical_global_hero.jpg\" class=\"attachment-featuredImage size-featuredImage\" alt loading=\"lazy\" srcset=\"https:\/\/zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com\/wp-content\/uploads\/2021\/04\/Cervical_global_hero.jpg 620w, https:\/\/zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com\/wp-content\/uploads\/2021\/04\/Cervical_global_hero-300x168.jpg 300w, https:\/\/zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com\/wp-content\/uploads\/2021\/04\/Cervical_global_hero-220x123.jpg 220w, https:\/\/zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com\/wp-content\/uploads\/2021\/04\/Cervical_global_hero-150x84.jpg 150w\" sizes=\"auto, (max-width: 620px) 100vw, 620px\" data-attachment-id=\"18442\" data-permalink=\"https:\/\/scienceblog.cancerresearchuk.org\/2021\/04\/19\/18440\/cervical_global_hero\/\" data-orig-file=\"https:\/\/scienceblog.cancerresearchuk.org\/wp-content\/uploads\/2021\/04\/Cervical_global_hero.jpg\" data-orig-size=\"620,348\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Cervical_global_hero\" data-image-description data-medium-file=\"https:\/\/scienceblog.cancerresearchuk.org\/wp-content\/uploads\/2021\/04\/Cervical_global_hero-300x168.jpg\" data-large-file=\"https:\/\/scienceblog.cancerresearchuk.org\/wp-content\/uploads\/2021\/04\/Cervical_global_hero.jpg\"><\/div>\n<p>Last year, the World Health Organisation (WHO) announced an ambitious plan: to create a \u2018cervical cancer-free future\u2019. The potential reward is huge. If we succeed, cervical cancer will become the first cancer to be \u2018eliminated\u2019 on this scale.<\/p>\n<p>But right now, around the world, someone dies every 2 minutes from cervical cancer, with lower resource countries more heavily impacted by the disease.<\/p>\n<p>How do we get from figures like that to a world where cervical cancer is \u2018no longer a public health problem\u2019? And why cervical cancer in particular?<\/p>\n<p>To help us unpick the strategy, we spoke to Professor Peter Sasieni, one of our researchers whose work is focused on cancer prevention, screening and early detection.<\/p>\n<p>Sasieni has dedicated a large amount of his scientific career to understanding cervical cancer from a population perspective \u2013 understanding the disease not only in terms of its biology, but also in terms of the big picture: who is at greatest risk of getting cervical cancer? And what can society do to reduce that risk?<\/p>\n<p>Together, we talk through the commitment and innovation that will be needed to ensure this important milestone can become a reality.<\/p>\n<h2>Can cervical cancer be \u2018eliminated as a public health problem\u2019?<\/h2>\n<p>Let\u2019s get down to it \u2013 what does it actually mean to eliminate cervical cancer as a public health problem?<\/p>\n<p>There are some important nuances in language that Sasieni highlights here. It\u2019s crucial to differentiate <em>elimination as a public health problem<\/em> as opposed to <em>elimination (or eradication) of the disease<\/em>.<\/p>\n<p>Eradication of a disease in a country means there are no cases in that country. Smallpox, for example, has been eradicated worldwide. But elimination of a disease as a public health issue means to make it rare enough that it\u2019s seen as something that affects a few individuals rather than a common disease affecting society as a whole.<\/p>\n<p>\u201cHaving no cases left in the world is not WHO\u2019s goal with cervical cancer,\u201d he says. \u201cBut, if fewer than 4 women in every 100,000 worldwide each year were diagnosed with cervical cancer, that would be seen as eliminating it as a public health problem. To get there, we would need to prevent about 70% of cervical cancer around the world.\u201d<\/p>\n<p>So even if we do \u2018eliminate\u2019 cervical cancer, there will sadly still be people who develop it. But the goal is to make that number as small as possible.<\/p>\n<p>To get there, WHO has devised the 90-70-90 targets around HPV vaccination, cervical screening, and effective treatment. These are milestones to be achieved by 2030 in order to make sure the world is on the right track towards \u2018elimination\u2019.<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\" readability=\"11.617021276596\">\n<p lang=\"en\" dir=\"ltr\" xml:lang=\"en\">It&#8217;s <a href=\"https:\/\/twitter.com\/hashtag\/CervicalCancer?src=hash&amp;ref_src=twsrc%5Etfw\">#CervicalCancer<\/a> Awareness Month!<\/p>\n<p>Cervical cancer could be the first cancer EVER in the world to be eliminated, if<\/p>\n<p>9&#x20e3;0&#x20e3;% of girls are vaccinated<br \/>7&#x20e3;0&#x20e3;% of women are screened<br \/>9&#x20e3;0&#x20e3;% of women with cervical disease receive treatment <a href=\"https:\/\/t.co\/Ewsm6jN0UT\">pic.twitter.com\/Ewsm6jN0UT<\/a><\/p>\n<p>\u2014 World Health Organization (WHO) (@WHO) <a href=\"https:\/\/twitter.com\/WHO\/status\/1347508905027526657?ref_src=twsrc%5Etfw\">January 8, 2021<\/a><\/p>\n<\/blockquote>\n<h2>Why cervical cancer and why now?<\/h2>\n<p>\u201cWhy WHO have decided that now is the right time to implement a global strategy to eliminate cervical cancer as a public health problem is essentially because of the success of the HPV vaccine,\u201d Sasieni explains.<\/p>\n<p>Cervical cancer is unusual in that virtually all cases are caused by a virus called human papillomavirus (HPV), making it one of the most preventable cancer types.<\/p>\n<p>HPV is an extremely common infection that infects the skin and cells lining the inside of the body. In most people, it doesn\u2019t cause any problems at all.<\/p>\n<p>There are over 100 types of the virus, and around 13 strains are known to be linked to cancer. \u201cThese strains can live in the cervix without you knowing for years and years, and then suddenly start causing a major health issue,\u201d says Sasieni.<\/p>\n<p><span data-contrast=\"auto\">The link between HPV and<\/span> <span data-contrast=\"auto\">cervical cancer was<\/span> <span data-contrast=\"auto\">established<\/span> <span data-contrast=\"auto\">i<\/span><span data-contrast=\"auto\">n 1999,<\/span> <span data-contrast=\"auto\">when<\/span> <span data-contrast=\"auto\">a group of scientists, including Cancer Research UK scientist Professor Julian Peto, found that virtually all cervical cancer samples<\/span> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10451482\/\"><span data-contrast=\"none\">contained the virus.<\/span><\/a><\/p>\n<p><span data-contrast=\"auto\">Together, researchers proved that<\/span> <span data-contrast=\"auto\">some<\/span> <span data-contrast=\"auto\">HPV<\/span> <span data-contrast=\"auto\">strains can cause<\/span> <span data-contrast=\"auto\">cervical cancer. This was, and remains to this day<\/span><span data-contrast=\"auto\">,<\/span> <span data-contrast=\"auto\">the risk factor that causes the largest proportion of a specific cancer worldwide<\/span><span data-contrast=\"auto\">.<\/span> <span data-contrast=\"auto\">And it also gave scientists a<\/span> <span data-contrast=\"auto\">new<\/span> <span data-contrast=\"auto\">potential way to prevent the disease.<\/span><\/p>\n<p><span data-contrast=\"auto\">Years of international work<\/span><span data-contrast=\"auto\">, including a number of<\/span> <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC402081\/?page=3\"><span data-contrast=\"none\">significant results<\/span><\/a> <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC556787\/?page=1\"><span data-contrast=\"none\">from our<\/span><\/a> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10451482\/\"><span data-contrast=\"none\">scientists<\/span><\/a><span data-contrast=\"auto\">,<\/span> <span data-contrast=\"auto\">resulted in the development of a<\/span> <span data-contrast=\"auto\">number of<\/span> <span data-contrast=\"auto\">vaccine<\/span><span data-contrast=\"auto\">s<\/span> <span data-contrast=\"auto\">that can prevent HPV infection<\/span><span data-contrast=\"auto\">.<\/span> <span data-contrast=\"auto\">And after many promising signs,<\/span> <a href=\"https:\/\/www.cancerresearchuk.org\/about-us\/cancer-news\/news-report\/2020-10-01-hpv-vaccine-reduces-cervical-cancer-risk\"><span data-contrast=\"none\">in 2020<\/span><\/a> <span data-contrast=\"auto\">the world got the first<\/span> <span data-contrast=\"auto\">definitive evidence that vaccination could also<\/span> <span data-contrast=\"auto\">reduce cervical cancer risk.<\/span><\/p>\n<p><span data-contrast=\"auto\">But vaccination is only part of the equation<\/span><span data-contrast=\"auto\">,<\/span> <span data-contrast=\"auto\">Sasieni<\/span> <span data-contrast=\"auto\">explains.<\/span> <span data-contrast=\"auto\">\u201c<\/span><span data-contrast=\"auto\">R<\/span><span data-contrast=\"auto\">elying only on vaccination means you\u2019re looking at elimination in only<\/span> <span data-contrast=\"auto\">people who have received the vaccine<\/span> <span data-contrast=\"auto\">before exposure to HPV infection<\/span><span data-contrast=\"auto\">.<\/span> <span data-contrast=\"auto\">So<\/span> <span data-contrast=\"auto\">it\u2019s important to have a combined strategy because otherwise you would only remove the disease amongst<\/span> <span data-contrast=\"auto\">those<\/span> <span data-contrast=\"auto\">people<\/span><span data-contrast=\"auto\">, which at the moment<\/span> <span data-contrast=\"auto\">doesn\u2019t include people<\/span> <span data-contrast=\"auto\">over about 30<\/span><span data-contrast=\"auto\">,<\/span> <span data-contrast=\"auto\">because of when vaccination started<\/span><span data-contrast=\"auto\">.<\/span><span data-contrast=\"auto\">\u201d<\/span><\/p>\n<p><span data-contrast=\"auto\">So<\/span> <span data-contrast=\"auto\">as well as the current vaccination programme, the strategy outlines how to effectively implement cervical screening across the world.<\/span><\/p>\n<div class=\"info-box-full-width-no-bg\" readability=\"6.2537537537538\">\n<p><strong><span data-contrast=\"auto\">Screening and vaccination in the UK<\/span><\/strong><\/p>\n<ul>\n<li><span data-contrast=\"auto\">In 200<\/span><span data-contrast=\"auto\">8<\/span><span data-contrast=\"auto\">, the UK implemented<\/span> <span data-contrast=\"auto\">a<\/span><span data-contrast=\"auto\">n<\/span> <span data-contrast=\"auto\">HPV immunisation programme<\/span> <span data-contrast=\"auto\">for adolescent girls<\/span><span data-contrast=\"auto\">.<\/span><\/li>\n<li><span data-contrast=\"auto\">The<\/span> <span data-contrast=\"auto\">HPV<\/span> <span data-contrast=\"auto\">vaccine<\/span> <span data-contrast=\"auto\">offered by health services in the UK<\/span> <span data-contrast=\"auto\">protects against the<\/span> <span data-contrast=\"auto\">2<\/span> <span data-contrast=\"auto\">main<\/span> <span data-contrast=\"auto\">types of HPV<\/span> <span data-contrast=\"auto\">that<\/span> <span data-contrast=\"auto\">together cause around 7 in 10 cervical cancer cases in the<\/span> <span data-contrast=\"auto\">UK<\/span><span data-contrast=\"auto\">.<\/span><\/li>\n<li><span data-contrast=\"auto\">This<\/span> <span data-contrast=\"auto\">is<\/span> <span data-contrast=\"auto\">now<\/span> <span data-contrast=\"auto\">offered<\/span> <span data-contrast=\"auto\">to all children aged 11 to 13 years<\/span> <span data-contrast=\"auto\">old<\/span> <span data-contrast=\"none\">and is available on request to girls up to the age of<\/span> <span data-contrast=\"none\">25<\/span><span data-contrast=\"none\">.<\/span><\/li>\n<li>The UK currently has a national cervical screening programme, which tests for HPV.<\/li>\n<li><span data-contrast=\"auto\">The screening programme invites women from age 25 to 64 for cervical screening, and cervical screening is also<\/span> <span data-contrast=\"auto\">for<\/span> <span data-contrast=\"none\"><a href=\"https:\/\/www.cancerresearchuk.org\/about-cancer\/screening\/trans-and-non-binary-cancer-screening\">trans men and non-binary people within this age range who have a cervix<\/a>.<\/span><\/li>\n<\/ul>\n<\/div>\n<p>While screening and vaccination mean that elimination as a public health problem is a possibility, it has been projected that without further intervention, there would be 44.4 million cervical cancer cases diagnosed globally over the next 50 years.<\/p>\n<p>And the burden of this disease falls heavily on women who live in the world\u2019s poorest countries. As echoed by WHO, \u201cfew diseases reflect global inequities as much as cancer of the cervix\u201d.<\/p>\n<h2><span class=\"TextRun SCXW13816885 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW13816885 BCX4\" data-ccp-charstyle=\"Heading 2 Char\">Elimination means elimination for all<\/span><\/span><\/h2>\n<p><span class=\"TextRun SCXW48218230 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW48218230 BCX4\">R<\/span><\/span><span class=\"TextRun SCXW48218230 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW48218230 BCX4\">ight now, the burden of cervical cancer falls predominantly on women in<\/span><\/span> <span class=\"TextRun SCXW48218230 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW48218230 BCX4\">lower-resource<\/span><\/span> <span class=\"TextRun SCXW48218230 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW48218230 BCX4\">countries<\/span><\/span><span class=\"TextRun SCXW48218230 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW48218230 BCX4\">, which account for<\/span><\/span> <a class=\"Hyperlink SCXW48218230 BCX4\" href=\"https:\/\/www.thelancet.com\/journals\/langlo\/article\/PIIS2214-109X(19)30482-6\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener\"><span class=\"TextRun Underlined SCXW48218230 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW48218230 BCX4\" data-ccp-charstyle=\"Hyperlink\">84% of cases and 90% of deaths<\/span><\/span><\/a> <span class=\"TextRun SCXW48218230 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW48218230 BCX4\">from cervical cancer.<\/span><\/span><\/p>\n<p>\u201cIt\u2019s still a majorly important cancer, globally, affecting women relatively young. And with very high mortality rates in many countries,\u201d says Sasieni. As WHO highlights, many of the women affected by cervical cancer have young children, impacting the entire family.<\/p>\n<p>And for women with HIV, the chance of developing cervical cancer is 6 times higher than women who don\u2019t have the virus.<\/p>\n<p>Between 2006 \u2013 when the first HPV vaccine was approved \u2013 and 2014, more than 59 million girls worldwide received at least a single dose of the HPV vaccine. But when talking about the success of HPV vaccination, it\u2019s important to note that only 15% of girls globally have been fully vaccinated.<\/p>\n<p>Although the means for eliminating cervical cancer exist, they have not yet been widely actualised in parts of the world where the disease burden is greatest.<\/p>\n<p>Now is the time to use the goal of elimination to motivate changes on the ground.<\/p>\n<h2>Overcoming barriers to vaccination<\/h2>\n<p>Sasieni highlights that both vaccination and screening programmes vary on an international level. And both are extremely hard to implement and require a strong healthcare infrastructure.<br \/>WHO notes that high vaccine prices and recent supply challenges, in combination with issues of acceptance amongst the public, have made it difficult for many countries to introduce HPV vaccination or maintain existing programmes.<\/p>\n<p>As of 2020, fewer than 25% of low-income countries and fewer than 30% of lower-middle-income countries had introduced the HPV vaccine into their national immunisation programmes. This contrasts with more than 85% of high-income countries who have done so.<\/p>\n<p>The first HPV vaccine approved for use was developed with the intention that every girl would receive 3 doses over a number of months. \u201cThe vaccine had to be kept in the fridge, you couldn\u2019t freeze it, and you couldn\u2019t let it get to room temperature. So that created a lot of logistical issues for trying to do it globally.\u201d<\/p>\n<p>But as well as storage, price was a huge challenge in a number of healthcare settings. \u201cI think when the vaccines came out, it cost about $100 per dose. So $300 just to vaccinate one woman, making it near impossible for some places to afford.\u201d<\/p>\n<p>But things could be changing, as scientists look to reduce the number of doses.<\/p>\n<p>\u201cIt\u2019s now accepted that actually, 2 doses of the vaccine, instead of 3 is sufficient,\u201d says Sasieni. This is reflected in WHO\u2019s current guidelines, which recommend that girls aged 9 to 14 receive 2 doses of vaccine to be fully protected.<\/p>\n<p>\u201cBut there\u2019s increasing evidence that even one dose is really effective. And I would say that the evidence that one dose is more than half as good as 2 doses is extremely strong.\u201d<\/p>\n<p><span class=\"TextRun SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34701553 BCX4\">It\u2019s a theory we\u2019re putting to the test.<\/span><\/span> <span class=\"TextRun SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34701553 BCX4\">Together, with the Bill and Melinda Gates Foundation and the National Cancer Institute, we\u2019re co-funding the<\/span><\/span> <a class=\"Hyperlink SCXW34701553 BCX4\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03728881\" target=\"_blank\" rel=\"noreferrer noopener\"><span class=\"TextRun Underlined SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW34701553 BCX4\" data-ccp-charstyle=\"Hyperlink\">PRIMAVERA trial<\/span><\/span><\/a><span class=\"TextRun SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34701553 BCX4\">.<\/span><\/span> <span class=\"TextRun SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34701553 BCX4\">B<\/span><\/span><span class=\"TextRun SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34701553 BCX4\">ased<\/span><\/span> <span class=\"TextRun SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34701553 BCX4\">in Costa Rica<\/span><\/span><span class=\"TextRun SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34701553 BCX4\">, the trial<\/span><\/span> <span class=\"TextRun SCXW34701553 BCX4\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW34701553 BCX4\">is testing the potential of a single dose vaccine in preventing HPV infection and ultimately, cervical and other HPV-related cancers.<\/span><\/span><\/p>\n<p>Although the study won\u2019t be completed until 2023, if the results find that a single dose can trigger the same immune response against HPV, it could have a big impact on global vaccination efforts. To put it simply, countries would be able to double the number of girls vaccinated with the stocks available.<\/p>\n<p>Sasieni weighs up the options. In his mind, the answer is clear. \u201cIf you said, well, I\u2019ve got a million doses for this particular part of the world, should I try to vaccinate half a million women with 2 doses each, or a million women with 1 dose? I think if you are limited in your resource, then it\u2019s pretty clear that that 1 dose for a million women is maximising the benefit of that resource.\u201d<\/p>\n<p>Reducing cost is a big step in the right direction, but it\u2019s not the only step needed.<\/p>\n<p>Another important step is recognising cultural barriers that might exist towards getting vaccinated, \u201cI think it\u2019s essential to understand cultural issues around vaccination, and people\u2019s attitudes to vaccines.<\/p>\n<p>\u201cFor HPV vaccination, there are additional concerns related to the fact that the virus is sexually transmitted. Some communities fear that the HPV vaccine might encourage promiscuity for example, because if someone\u2019s been vaccinated against it, they might no longer worry about getting a sexually transmitted infection, or they might view having the vaccine as a \u2018green light\u2019 to become sexually active at an earlier age\u201d says Sasieni.<\/p>\n<p>\u201cThere\u2019s no scientific basis for thinking that people change their behaviour after getting vaccinated, but making it clear that this is a vaccine against cancer, is really important.\u201d<\/p>\n<p>And as Sasieni explains, vaccination alone is not the answer.<\/p>\n<h2>National screening programmes<\/h2>\n<p>\u201cLots of my research has been linked to cervical screening,\u201d says Sasieni.<\/p>\n<p>Like HPV vaccination, \u201cscreening is very difficult to do well, and you need a pretty good health infrastructure. You need something that enables you to identify everyone in the population. Because otherwise, the people that will get screened will be those who are better off. So the first hurdle is you need to be able to invite everybody to do the screening.\u201d<\/p>\n<p>Cervical screening (previously known as a \u2018smear test\u2019) involves collecting samples of cells from the cervix using a small, soft brush, and then analysing those cells in the laboratory.<\/p>\n<p>In England, Scotland and Wales, the lab will first check if the sample has high risk HPV. High risk HPV can cause cell changes in the cervix, which over time can develop into cancer. If a sample has high risk HPV, the laboratory will examine the sample under a microscope to look for cell changes, and if cell changes are found, the person will be invited for a follow up test called a colposcopy.<\/p>\n<p>But trying to replicate this in countries around the world may not be the best approach. With this process, transporting samples to the lab can throw up logistical problems that are hard to overcome. \u201cIf you\u2019re in countries where it can get up to 40 or 50 degrees Celsius, putting samples in the post can cause problems where we can\u2019t rely on the results of the test when the sample\u2019s been at that sort of temperature for a number of hours.<\/p>\n<p>\u201cThis type of molecular test is also difficult to organise in countries without a good health care infrastructure, and the biggest problem then is getting the test results to the women and ensuring that treatment is available.\u201d<\/p>\n<p>Sasieni mentions other ways of studying the cells, that can remove the difficult process of having to analyse them under a microscope in the lab. \u201cI think, and possibly again with COVID-19, people will see that actually, there are a number of ways you can test for DNA,\u201d he says.<\/p>\n<p>\u201cThere may be new technologies that are allow rapid point of care testing, so that you could start having screening programmes go into rural villages or crowded urban areas and get screening results back in an hour.\u201d<\/p>\n<p>In the last few years, scientists have developed HPV tests based on LAMP technology \u2013 a technique also used for rapid COVID-19 testing, which allows for the quick amplification and testing of DNA.<br \/>But the options don\u2019t end there. \u201cThere are other HPV tests which can be done using a portable machine no bigger than a home printer,\u201d Sasieni adds. \u201cAs well as several companies that are developing devices like mobile phones that take photographs or videos of the cervix and analyse them in real-time using artificial intelligence.\u201d<\/p>\n<h2>Barriers and inequalities in screening<\/h2>\n<p>Getting the logistics right is the first hurdle, but it\u2019s not the only one.<\/p>\n<p>\u201cWithin countries there are almost certainly inequalities in terms of groups who are deprived because of language and ethnicity and access to healthcare communications. In many cultures, in families who have immigrated, women are less likely to know the language than men.<\/p>\n<p>\u201cOr, for example, if screening or intimate examination is done by a man, that would not be acceptable in some cultures.\u201d<\/p>\n<p>WHO\u2019s strategy has outlined that strong communication strategies for effective advocacy can overcome the many challenges that might limit access to cervical cancer prevention and care, but that this content must be culturally relevant and context-specific.<\/p>\n<p>This same sentiment is echoed by Sasieni, \u201cyou can\u2019t just say one size fits all for how you should implement this strategy worldwide. Because there are a whole variety of things that need to be considered, from healthcare priorities, to infrastructure, to international trade.\u201d<\/p>\n<p>Another point that Sasieni draws attention to is the need for a national screening programme to establish who they\u2019ll invite for screening.<\/p>\n<p>\u201cOne of the things that I\u2019ve been trying to do with WHO is to get across this idea that there needs to be a catch up for screening, that we shouldn\u2019t just write off everyone born before 1975, or maybe even 1980.\u201d<\/p>\n<p>But despite Sasieni\u2019s efforts, there\u2019s talk about not offering any screen to anyone over 45. \u201cBy the time a screening programme is put into place, that could mean that anyone born before 1980 won\u2019t benefit from WHO\u2019s efforts to eliminate cervical cancer. And that would be tragic.\u201d<\/p>\n<h2>Collaboration on a global scale<\/h2>\n<p>We\u2019ve barely scratched the surface on all the factors that need to be considered when implementing this global strategy. But it\u2019s clear that achieving cervical cancer elimination will not be possible without collaboration.<\/p>\n<p>The WHO details the role of civil society, women\u2019s groups, non-governmental organisations and a wide range of local networks being fundamental to the successful uptake of services at the community level.<\/p>\n<p>Our international cancer prevention programme is working with these organisations to advocate for greater HPV vaccine demand and acceptance around the world.<\/p>\n<p>On an international scale, Sasieni highlights that there\u2019s a lot that can be shared.<\/p>\n<p>\u201cWell, the UK has been really very involved in HPV vaccine research, and probably even more so, cervical screening research, HPV testing, and looking at biomarkers for triage,\u201d says Sasieni.<\/p>\n<p>\u201cSome people will think the problem has been somewhat solved in the UK. Regardless of that or not, it\u2019s up to all sorts of researchers to ensure that the progress is actually deliverable worldwide.\u201d<\/p>\n<p><em><br \/>Lilly<\/em><\/p>\n<p><h3 class=\"panel-title\">More on this topic<\/h3>\n<\/p>\n<p> <a href=\"http:\/\/feedproxy.google.com\/~r\/cancerresearchuk\/SHhE\/~3\/nq2lqGM6tYQ\/\">Source<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Last year, the World Health Organisation (WHO) announced an ambitious plan: to create a \u2018cervical cancer-free future\u2019. The potential reward is huge. If we succeed, cervical cancer will become the first cancer to be \u2018eliminated\u2019 on this scale. But right now, around the world, someone dies every 2 minutes from cervical cancer, with lower resource [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-26973","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=26973"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26973\/revisions"}],"predecessor-version":[{"id":43856,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26973\/revisions\/43856"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=26973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=26973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=26973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}